As of 1 July 2026, device registration in swissdamed is now mandatory for applicable medical devices, systems, and procedure packs placed on the Swiss market. This marks a major milestone in Switzerland’s modernization of medical device regulation and introduces new ongoing obligations for manufacturers and their Swiss Authorized Representatives (CH-REPs). Organizations that have not yet established their swissdamed registration processes should act quickly, while those already submitting device information should focus on building efficient processes that support ongoing compliance.

What Changed on 1 July 2026?

From 1 July 2026, manufacturers must ensure that applicable medical devices, systems, and procedure packs are registered in the swissdamed UDI Devices module before or as required for placement on the Swiss market. The mandatory device registration requirement follows the earlier rollout of the swissdamed Actor module, which has supported economic operator registration since 2024.

Manufacturers now need to:

• Register applicable devices in swissdamed
• Maintain accurate UDI and product information
• Update device records when product information changes
• Support ongoing regulatory traceability throughout the product lifecycle
• Ensure regulatory information remains accurate and up to date

Rather than being a one-time registration exercise, swissdamed introduces an ongoing responsibility to maintain trusted UDI data throughout the life of a medical device.

A Transition Period Is Available—but Planning Shouldn’t Wait

While mandatory registration began on 1 July 2026, Swissmedic has provided a transition period until 31 December 2026 for many existing devices already on the Swiss market.

Milestone	Timeline
Mandatory swissdamed device registration begins	1 July 2026
Transition period for many existing devices ends	31 December 2026

However, manufacturers should avoid treating the transition period as additional implementation time. Registering large product portfolios, validating product data, and resolving submission issues often require considerably more effort than anticipated.

swissdamed Is Similar to EUDAMED—But It Is Not the Same

Many global manufacturers assume that compliance with EUDAMED automatically satisfies Swiss requirements…it does not!

Although swissdamed closely aligns with European UDI principles and shares a similar data structure, it is a separate national database operated by Swissmedic, with its own regulatory processes, registrations, timelines, and submission requirements.

Manufacturers supplying both the European Union and Switzerland must therefore manage UDI compliance across two independent regulatory databases.

Swiss Authorized Representatives Play a Critical Role

Since Switzerland is outside the EU medical device regulatory framework, many foreign manufacturers must work through a Swiss Authorized Representative (CH-REP).

Successful swissdamed registration depends on close coordination between manufacturers and their CH-REP to ensure:

• Accurate economic operator registration
• Correct device information
• Consistent UDI data
• Timely submission of product updates
• Ongoing regulatory maintenance

Establishing clear governance between manufacturers and their Swiss regulatory partners becomes increasingly important as product portfolios expand.

Manual Registration Processes Quickly Become Difficult

Many organizations initially prepare swissdamed submissions manually using spreadsheets or portal-based data entry.

While manageable for a limited number of products, these approaches become increasingly challenging when manufacturers need to:

• Register thousands of devices
• Aggregate data from ERP, PLM, PIM, MDM, and regulatory systems
• Correct data validation errors
• Maintain consistency across EUDAMED and swissdamed
• Support ongoing product changes
• Monitor submission status and acknowledgements

As organizations expand internationally, maintaining separate manual processes for each regulator significantly increases operational complexity.

Trusted Product Data Is Essential for swissdamed Compliance

Successful device registration begins with high-quality product master data.

Common challenges include:

• Missing mandatory attributes
• Inconsistent UDI information
• Incorrect packaging hierarchies
• Data discrepancies between enterprise systems
• Data validation failures requiring manual correction

Organizations with mature product data governance are generally able to achieve higher submission success while reducing the operational effort required to maintain compliance.

Automation Helps Manufacturers Scale UDI Compliance Operations

As regulatory obligations continue to expand, many manufacturers are moving beyond manual registration toward automated UDI data management, validation, and submission processes.

Modern and reliable UDI submission solutions help organizations:

• Integrate with ERP, PLM, PIM, MDM, and regulatory systems
• Validate against Swiss-specific business rules before submission
• Support machine-to-machine (M2M) submissions where appropriate
• Track submission status and acknowledgements
• Maintain complete audit trails
• Reuse trusted product data across multiple global UDI databases

Rather than maintaining isolated UDI data repositories, manufacturers can leverage existing enterprise systems for core product data while automating country-specific submission requirements.

Switzerland Is Part of a Broader Global UDI Strategy

For many manufacturers, Switzerland represents one component of an expanding global UDI landscape.

Organizations increasingly need to support multiple UDI databases, including:

• Switzerland (swissdamed)
• Australia (AusUDID)
• European Union (EUDAMED)
• United States (GUDID)
• Additional global UDI programs as they become operational

A centralized UDI submission strategy helps organizations reduce duplicate effort while improving data quality and operational efficiency across global markets.

Questions Manufacturers Should Be Asking

Now that swissdamed registration is mandatory, manufacturers should evaluate whether they are prepared for ongoing compliance with evolving regulations.

Consider asking:

• Can we efficiently maintain swissdamed records as products evolve?
• Are our Swiss submissions integrated with our global UDI processes?
• Is our product data validated before submission?
• Can we quickly resolve data submission and validation issues?
• Are we coordinating effectively with our Swiss Authorized Representative?
• Can our current approach scale as our product portfolio grows?

These questions can help identify opportunities to strengthen both compliance and operational performance.